Cardiac Complications of Tricyclic Antidepressant Therapy
Authors:
- 1 March 1971
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 74 (3) , 395-398
Abstract
Two similar cases of unresponsive cardiac standstill secondary to toxicity of tricyclic antidepressants are reported. One is a case of deliberate overdose, and the other represents toxicity of therapeutic doses in a patient "pretreated" with a catecholamine depleting agent (guanethidine). Tricyclicamine antidepressants block the uptake of catecholamines by the heart, allowing enzymatic degradation and further catecholamine depletion. This group of antidepressants should therefore be contraindicated in patients receiving drugs that deplete cardiac catecholamines.Keywords
This publication has 20 references indexed in Scilit:
- Cardiovascular Complications of Imipramine IntoxicationJAMA, 1968
- Dual actions of guanethidine on amine uptake mechanisms in adrenergic neuronsBiochemical Pharmacology, 1966
- AMITRIPTYLINE POISONINGThe Lancet, 1965
- AMITRIPTYLINE AND IMIPRAMINE POISONINGThe Lancet, 1965
- AMITRIPTYLINE POISONINGThe Lancet, 1965
- The effect of amitriptyline on glycogen phosporylase in cardiac muscleBiochemical Pharmacology, 1964
- Release and depletion of the transmitter in adrenergic terminals produced by nerve impulses after the inhibition of noradrenaline synthesis or reabsorptionLife Sciences, 1964
- Amitriptyline PoisoningAmerican Journal of Diseases of Children, 1963
- AMITRIPTYLINE POISONINGThe Lancet, 1963
- Effect of Drugs on the Uptake and Release of 3H-Norepinephrine in the Rat HeartNature, 1962